{"title":"2021年药物治疗失败","authors":"F. Moiseyenko, V. Moiseenko, E. V. Artemeva","doi":"10.31917/2301023","DOIUrl":null,"url":null,"abstract":"The development of all scientific problems is driven by new results of various research efforts. While positive data is usually widely disseminated, negative trials very often are not published at all. Still we think that the role of negative data n driving science forward is as important as is of positive trials. The aim of this review is to discuss the most important negative results showed during previous year.","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"02 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2021 failures in drug therapy\",\"authors\":\"F. Moiseyenko, V. Moiseenko, E. V. Artemeva\",\"doi\":\"10.31917/2301023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The development of all scientific problems is driven by new results of various research efforts. While positive data is usually widely disseminated, negative trials very often are not published at all. Still we think that the role of negative data n driving science forward is as important as is of positive trials. The aim of this review is to discuss the most important negative results showed during previous year.\",\"PeriodicalId\":101072,\"journal\":{\"name\":\"Reports of Practical Oncology\",\"volume\":\"02 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Practical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31917/2301023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31917/2301023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The development of all scientific problems is driven by new results of various research efforts. While positive data is usually widely disseminated, negative trials very often are not published at all. Still we think that the role of negative data n driving science forward is as important as is of positive trials. The aim of this review is to discuss the most important negative results showed during previous year.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
